Chronic liver disease is one of the most common diseases worldwide, and its prevalence is particularly high among adults aged 40–60 years; it takes a toll on productivity and causes significant economic burden. However, there are still no effective treatments that can fundamentally treat chronic liver disease. Although liver transplantation is considered the only effective treatment for chronic liver disease, it has limitations in that the pool of available donors is vastly insufficient for the number of potential recipients. Even if a patient undergoes liver transplantation, side effects such as immune rejection or bile duct complications could occur. In addition, impaired liver regeneration due to various causes, such as aging and metabolic disorders, may cause liver failure after liver resection, even leading to death. Therefore, further research on the liver regeneration process and therapeutic strategies to improve liver regeneration are needed. In this review, we describe the process of liver regeneration after hepatectomy, focusing on various cytokines and signaling pathways. In addition, we review treatment strategies that have been studied to date to improve liver regeneration, such as promotion of hepatocyte proliferation and metabolism and transplantation of mesenchymal stem cells. This review helps to understand the physiological processes involved in liver regeneration and provides basic knowledge for developing treatments for successful liver regeneration.
MichalopoulosGKBhushanB. Liver regeneration: biological and pathological mechanisms and implications.Nat Rev Gastroenterol Hepatol2021;18:40–55
9.
YagiSHirataMMiyachiYUemotoS. Liver regeneration after hepatectomy and partial liver transplantation.Int J Mol Sci2020;21:8414
10.
CienfuegosJARotellarFBaixauliJMartínez-RegueiraFPardoFHernández-LizoáinJL. Liver regeneration – the best kept secret. A model of tissue injury response.Rev Esp Enferm Dig2014;106:171–94
11.
HuangJSchrieferAECliftenPFDietzenDKulkarniSSingSMongaSPRudnickDA. Postponing the hypoglycemic response to partial hepatectomy delays mouse liver regeneration.Am J Pathol2016;186:587–99
12.
CaruanaJAWhalenDAJrAnthonyWPSunbyCRCiechoskiMP. Paradoxical effects of glucose feeding on liver regeneration and survival after partial hepatectomy.Endocr Res1986;12:147–56
13.
ChioléroRTappyLGilletMRevellyJPRothHCayeuxCSchneiterPLeverveX. Effect of major hepatectomy on glucose and lactate metabolism.Ann Surg1999;229:505–13
14.
Abu RmilahAZhouWNelsonELinLAmiotBNybergSL. Understanding the marvels behind liver regeneration.Wiley Interdiscip Rev Dev Biol2019;8:e340
NewberryEPKennedySMXieYLuoJStanleySESemenkovichCFCrookeRMGrahamMJDavidsonNO. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.Hepatology2008;48:1097–105
17.
RudnickDADavidsonNO. Functional relationships between lipid metabolism and liver regeneration.Int J Hepatol2012;2012:549241
18.
SakamotoTLiuZMuraseNEzureTYokomuroSPoliVDemetrisAJ. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy.Hepatology1999;29:403–11
YangLMagnessSTBatallerRRippeRABrennerDA. NF-kappaB activation in Kupffer cells after partial hepatectomy.Am J Physiol Gastrointest Liver Physiol2005;289:G530–8
23.
WuestefeldTKleinCStreetzKLBetzULauberJBuerJMannsMPMüllerWTrautweinC. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration.J Biol Chem2003;278:11281–8
24.
WenYFengDWuHLiuWLiHWangFXiaQGaoWQKongX. Defective initiation of liver regeneration in osteopontin-deficient mice after partial hepatectomy due to insufficient activation of IL-6/Stat3 pathway.Int J Biol Sci2015;11:1236–47
25.
SuAIGuidottiLGPezackiJPChisariFVSchultzPG. Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice.Proc Natl Acad Sci U S A2002;99:11181–6
26.
HoffmannKNagelAJTanabeKFuchsJDehlkeKGhamarnejadOLemekhovaAMehrabiA. Markers of liver regeneration – the role of growth factors and cytokines: a systematic review.BMC Surg2020;20:31
27.
JacksonLNLarsonSDSilvaSRRychahouPGChenLAQiuSRajaramanSEversBM. PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy.Am J Physiol Gastrointest Liver Physiol2008;294:G1401–10
28.
LaiSSZhaoDDCaoPLuKLuoOYChenWBLiuJJiangEZYuZHLeeGLiJYuDCXuXJZhuMSGaoXLiCJXueB. PP2Acα positively regulates the termination of liver regeneration in mice through the AKT/GSK3β/Cyclin D1 pathway.J Hepatol2016;64:352–60
29.
MongaSP. Role and regulation of β-catenin signaling during physiological liver growth.Gene Expr2014;16:51–62
30.
ZouGParkJI. WNT signaling in liver regeneration, disease, and cancer.Clin Mol Hepatol2023;29:33–50
31.
BöhmFKöhlerUASpeicherTWernerS. Regulation of liver regeneration by growth factors and cytokines.EMBO Mol Med2010;2:294–305
32.
LiYLuLCaiX. Liver regeneration and cell transplantation for end-stage liver disease.Biomolecules2021;11:1907
33.
AlarcónCZaromytidouAIXiQGaoSYuJFujisawaSBarlasAMillerANManova-TodorovaKMaciasMJSapkotaGPanDMassaguéJ. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways.Cell2009;139:757–69
34.
RaySMehtaNNGolharANundyS. Post hepatectomy liver failure – a comprehensive review of current concepts and controversies.Ann Med Surg2018;34:4–10
35.
OcakİTopaloğluSAcarliK. Posthepatectomy liver failure.Turk J Med Sci2020;50:1491–503
36.
GilgSSandströmPRizellMLindellGArdnorBStrömbergCIsakssonB. The impact of post-hepatectomy liver failure on mortality: a population-based study.Scand J Gastroenterol2018;53:1335–9
37.
TaoYWangMChenETangH. Liver regeneration: analysis of the main relevant signaling molecules.Mediators Inflamm2017;2017:4256352
38.
SgroiAGonelle-GispertCMorelPBaertschigerRMNiclaussNMenthaGMajnoPSerre-BeinierVBuhlerL. Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice.PLoS ONE2011;6:e25442
39.
KalininEVChalenkoYMSysolyatinaEVMidiberKYGusarovAMKechkoOIKulikovaAAMikhalevaLMMukhachevAYStanishevskyiYMMitkevichVASobyaninKAErmolaevaSA. Bacterial hepatocyte growth factor receptor agonist stimulates hepatocyte proliferation and accelerates liver regeneration in a partial hepatectomy rat model.Drug Dev Res2021;82:123–32
40.
MaYLvXHeJLiuTWenSWangL. Wnt agonist stimulates liver regeneration after small-for-size liver transplantation in rats.Hepatol Res2016;46:E154–64
41.
AlvaradoTFPuligaEPreziosiMPoddarMSinghSColumbanoANejak-BowenKMongaSP. Thyroid hormone receptor β agonist induces β-catenin-dependent hepatocyte proliferation in mice: implications in hepatic regeneration.Gene Expr2016;17:19–34
42.
SongJWuXMaRMiaoLXiongLZhaoW. Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt/β-catenin signaling in prostate cancer through sponging microRNA-195.J Cell Biochem2019;120:13066–75
43.
DingSQuWJiaoYZhangJZhangCDangS. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.Cancer Biomark2018;22:217–26
44.
ZhuYQiuZZhangYLiBJiangX. Partial hepatectomy-induced upregulation of SNHG12 promotes hepatocyte proliferation and liver regeneration.Mol Med Rep2020;21:1089–96
45.
LiuMChenP. Proliferation-inhibiting pathways in liver regeneration (Review).Mol Med Rep2017;16:23–35
46.
LuSShenKCWangYBrooksSCWangYA. Impaired hepatocyte survival and liver regeneration in Atm-deficient mice.Hum Mol Genet2005;14:3019–25
47.
RitschkaBKnauer-MeyerTGonçalvesDSMasAPlassatJLDurikMJacobsHPedoneEDi VicinoUCosmaMPKeyesWM. The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice.Genes Dev2020;34:489–94
48.
ZhangBMengFLiuYYuanYWangJWuDCuiYZhangSGuoHLiangSWangWKlosMMorgensternSLiuYSunLMaKLiuXWangYHanJYangGZhengCLiXZhouSJiCBaiQWangJLiuL. Inhibition of TGFβ1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomy.Theranostics2021;11:4743–58
49.
ZhaoYTranMWangLShinDJWuJ. PDK4-deficiency reprograms intrahepatic glucose and lipid metabolism to facilitate liver regeneration in mice.Hepatol Commun2020;4:504–17
50.
ValdecantosMPPardoVRuizLCastro-SánchezLLanzónBFernández-MillánEGarcía-MonzónCArrobaAIGonzález-RodríguezÁEscriváFÁlvarezCRupérezFJBarbasCKonkarANaylorJHornigoldDSantosADBednarekMGrimsbyJRondinoneCMValverdeÁM. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.Hepatology2017;65:950–68
51.
KernMKosackaJHesselbarthNBrücknerJHeikerJTFlehmigGKlötingIKovacsPMatz-SojaMGebhardtRKrohnKSalesSAbshagenKShevchenkoAStumvollMBlüherMKlötingN. Liver-restricted Repin1 deficiency improves whole-body insulin sensitivity, alters lipid metabolism, and causes secondary changes in adipose tissue in mice.Diabetes2014;63:3295–309
MagnussonBAspLBoströmPRuizMStillemark-BilltonPLindénDBorénJOlofssonSO. Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins.Arterioscler Thromb Vasc Biol2006;26:1566–71
54.
KohjimaMTsaiTHTackettBCThevanantherSLiLChangBHChanL. Delayed liver regeneration after partial hepatectomy in adipose differentiation related protein-null mice.J Hepatol2013;59:1246–54
55.
ZhangLMaXJFeiYYHanHTXuJChengLLiX. Stem cell therapy in liver regeneration: focus on mesenchymal stem cells and induced pluripotent stem cells.Pharmacol Ther2022;232:108004
56.
Van PollDParekkadanBChoCHBerthiaumeFNahmiasYTillesAWYarmushML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo.Hepatology2008;47:1634–43
57.
WinklerSBorkham-KamphorstEStockPBrücknerSDollingerMWeiskirchenRChristB. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model.Exp Cell Res2014;326:230–9
58.
StockPBrücknerSWinklerSDollingerMMChristB. Human bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury.Int J Mol Sci2014;15:7004–28
59.
PapanikolaouIGKatselisCApostolouKFeretisTLymperiMKonstadoulakisMMPapaloisAEZografosGC. Mesenchymal stem cells transplantation following partial hepatectomy: a new concept to promote liver regeneration-systematic review of the literature focused on experimental studies in rodent models.Stem Cells Int2017;2017:7567958
60.
AlfaifiMEomYWNewsomePNBaikSK. Mesenchymal stromal cell therapy for liver diseases.J Hepatol2018;68:1272–85
61.
YuJYinSZhangWGaoFLiuYChenZZhangMHeJZhengS. Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model.Stem Cell Res Ther2013;4:83
62.
LiDLHeXHZhangSAFangJChenFSFanJJ. Bone marrow-derived mesenchymal stem cells promote hepatic regeneration after partial hepatectomy in rats.Pathobiology2013;80:228–34
63.
DingHRWangJLTangZTWangYZhouGLiuYRenHZShiXL. Mesenchymal stem cells improve glycometabolism and liver regeneration in the treatment of post-hepatectomy liver failure.Front Physiol2019;10:412
64.
WangJLDingHRPanCYShiXLRenHZ. Mesenchymal stem cells ameliorate lipid metabolism through reducing mitochondrial damage of hepatocytes in the treatment of post-hepatectomy liver failure.Cell Death Dis2021;12:111
65.
ArikuraJInagakiMHuilingXOzakiAOnoderaKOgawaKKasaiS. Colonization of albumin-producing hepatocytes derived from transplanted F344 rat bone marrow cells in the liver of congenic Nagase’s analbuminemic rats.J Hepatol2004;41:215–21
66.
LiuTMuHShenZSongZChenXWangY. Autologous adipose tissue-derived mesenchymal stem cells are involved in rat liver regeneration following repeat partial hepatectomy.Mol Med Rep2016;13:2053–9
67.
SekiTYokoyamaYNagasakiHKokuryoTNaginoM. Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats.J Surg Res2012;178:63–70
68.
WanCDChengRWangHBLiuT. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.Hepatobiliary Pancreat Dis Int2008;7:29–33
69.
GeYZhangQLiHBaiGJiaoZWangH. Adipose-derived stem cells alleviate liver apoptosis induced by ischemia-reperfusion and laparoscopic hepatectomy in swine.Sci Rep2018;8:16878
70.
DamaniaAJaimanDTeotiaAKKumarA. Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury.Stem Cell Res Ther2018;9:31
71.
LeeSCJeongHJLeeSKKimSJ. Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome.Stem Cell Res Ther2015;6:75
72.
FouraschenSMPanQde RuiterPEFaridWRKazemierGKwekkeboomJIjzermansJNMetselaarHJTilanusHWde JongeJvan der LaanLJ. Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy.Stem Cells Dev2012;21:2410–9
73.
HerreraMBFonsatoVGattiSDeregibusMCSordiACantarellaDCalogeroRBussolatiBTettaCCamussiG. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.J Cell Mol Med2010;14:1605–18
